Nov 09, 2017 21:06 pm UTC| Business
SANTA FE, N.M., Nov. 09, 2017 -- Sigma Labs, Inc. (NASDAQ:SGLB) (“Sigma Labs” or the “Company”), a provider of quality assurance software under the PrintRite3D® brand, today announced it will issue financial results for...
THL Credit Reports Third Quarter 2017 Financial Results and Declares a Dividend of $0.27 Per Share
Nov 09, 2017 21:06 pm UTC| Business
BOSTON, Nov. 09, 2017 -- THL Credit, Inc. (NASDAQ:TCRD) (“THL Credit” or the “Company”), a direct lender to lower middle market companies, today announced financial results for its third fiscal quarter ended September...
Esterline Reports Fiscal 2017 Fourth Quarter and Full-Year Financial Results
Nov 09, 2017 21:06 pm UTC| Business
Fiscal 2017 Fourth Quarter Results° Sales of $531.5 million° Earnings from continuing operations of $36.7 million, or $1.22 per diluted share° Adjusted earnings from continuing operations of $38.1 million, or $1.27 per...
Cyclacel Pharmaceuticals Reports Third Quarter 2017 Financial Results
Nov 09, 2017 21:06 pm UTC| Business
BERKELEY HEIGHTS, N.J., Nov. 09, 2017 -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of...
ICU Medical, Inc. Announces Third Quarter 2017 Results
Nov 09, 2017 21:06 pm UTC| Business
SAN CLEMENTE, Calif., Nov. 09, 2017 -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care applications, today...
Sphere 3D Reports Third Quarter Fiscal Year 2017 Financial Results
Nov 09, 2017 21:06 pm UTC| Business
SAN JOSE, Calif., Nov. 09, 2017 -- Sphere 3D Corp. (NASDAQ:ANY), a containerization, virtualization, and data management solutions provider, today reported financial results for its third quarter ended September 30,...
Ovid Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Progress
Nov 09, 2017 21:06 pm UTC| Business
NEW YORK, Nov. 09, 2017 -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines for patients with rare neurological diseases, today announced financial results for the...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update